Wan Sheng, Yang Yong, Zhao Qihan, Xing Zelong, Li Jie, Gao Hao, Yin Yinghui, Liu Zhenzhong, Chen Qiwen, Tian Maoqin, Shi Xinxin, Ji Ziyue, Huang Shaoxin
Jiangxi Provincial Key Laboratory of Cell Precision Therapy, School of Basic Medical Sciences, Jiujiang University, Jiujiang, 332005, Jiangxi, China.
School of Public Health, North Sichuan Medical College, Nanchong, 637000, China.
J Transl Med. 2025 May 1;23(1):499. doi: 10.1186/s12967-025-06466-7.
Emerging evidence implicates environmental contaminants such as cadmium (Cd) as modifiable risk factors for anxiety. Despite growing recognition of heavy metal toxicity in neuropsychiatric disorders, the molecular mechanisms linking environmental exposure to anxiety pathogenesis remain poorly understood.
Based on the established cohort of individuals with cognitive impairment in cadmium-contaminated areas, this cross-sectional association study enrolled 50 middle-aged and elderly hospitalized patients from these regions, adhering to the STROBE guidelines. Blood concentrations of cadmium (Cd), lead (Pb), and mercury (Hg) were analyzed in relation to anxiety severity assessed via the Hamilton Anxiety Rating Scale (HAMA). Plasma proteomic profiling was performed using data-independent acquisition (DIA) quantitative technology with an LC-MS/MS platform (timsTOF Pro, Bruker Daltonics), systematically characterizing 2,531 proteins across all samples. Machine learning techniques, specifically XGBoost and LASSO, were employed to identify biomarkers that were subsequently validated through mediation analysis and animal experiments, allowing for the screening of key protein signatures. Finally, clinical variables were integrated to construct a comprehensive model, which was then thoroughly evaluated.
Anxious individuals exhibited significantly higher blood Cd levels than controls (β = 0.50, 95% CI: 0.07-0.93, p < 0.01), with anxiety positively correlating with depression (r = 0.62, p = 0.003) and inversely with ApoE3 genotype prevalence. Proteomics identified 120 differentially expressed proteins in anxious patients, enriched in oxidative phosphorylation and neurodegenerative pathways. CCDC126 emerged as a cadmium-associated biomarker, validated in rat models exposed to Cd. Combining CCDC126, blood Cd, Pb, and hypertension, a clinical prediction model achieved robust discrimination (AUC = 0.80, validation cohort).
This first integrative environmental-proteomic study highlights cadmium's synergistic role in anxiety pathophysiology and psychiatric comorbidity. The predictive model offers translatable potential for early risk stratification, while CCDC126 provides mechanistic insights for targeted interventions in populations exposed to environmental pollutants.
新出现的证据表明,镉(Cd)等环境污染物是焦虑症的可改变风险因素。尽管人们越来越认识到重金属毒性在神经精神疾病中的作用,但环境暴露与焦虑症发病机制之间的分子机制仍知之甚少。
基于镉污染地区认知障碍个体的既定队列,这项横断面关联研究纳入了来自这些地区的50名中老年住院患者,遵循STROBE指南。分析了血液中镉(Cd)、铅(Pb)和汞(Hg)的浓度,并与通过汉密尔顿焦虑量表(HAMA)评估的焦虑严重程度相关联。使用具有LC-MS/MS平台(timsTOF Pro,布鲁克道尔顿公司)的数据非依赖采集(DIA)定量技术进行血浆蛋白质组学分析,系统地表征所有样本中的2531种蛋白质。采用机器学习技术,特别是XGBoost和LASSO,来识别生物标志物,随后通过中介分析和动物实验对其进行验证,从而筛选关键蛋白质特征。最后,整合临床变量构建一个综合模型,然后对其进行全面评估。
焦虑个体的血液Cd水平显著高于对照组(β = 0.50,95% CI:0.07 - 0.93,p < 0.01),焦虑与抑郁呈正相关(r = 0.62,p = 0.003),与ApoE3基因型患病率呈负相关。蛋白质组学鉴定出焦虑患者中有120种差异表达蛋白质,富集于氧化磷酸化和神经退行性途径。CCDC126成为一种与镉相关的生物标志物,在暴露于Cd的大鼠模型中得到验证。结合CCDC126、血液Cd、Pb和高血压,一个临床预测模型实现了强大的辨别力(AUC = 0.80,验证队列)。
这项首次整合环境 - 蛋白质组学的研究突出了镉在焦虑症病理生理学和精神共病中的协同作用。该预测模型为早期风险分层提供了可转化的潜力,而CCDC126为针对暴露于环境污染物人群的靶向干预提供了机制性见解。